Theradiag, a French company specialising in theranostics and in vitro diagnostics (IVD), has appointed two new Vice Presidents for its business units, in line with the organisation of the company in two divisions.
Odile Prigneau, previously Head of Marketing, is also named as General Manager of Prestizia.
Philippe Lestage and Valery Labonne will lead the In vitro Diagnostics (IVD) and Theranostics divisions, respectively.
Lestage joins Theradiag from Ortho Clinical Diagnostics, a Johnson & Johnson company, where most recently he held the position of Marketing Director Transfusion Medecine for Europe. He will head the IVD business unit, responsible for commercial operations, marketing and customer service for France and international markets.
Labonne, former Marketing Director at Boehringer Ingelheim and Co-Founder of StarGen Consulting, will lead the Theranostics business unit and oversee domestic and international sales and marketing.
Prigneau, is appointed as General Manager of Prestizia, Theradiag's subsidiary dedicated to microRNAs. She brings to Prestizia significant experience in molecular biology. She will retain her business development responsibilities within Theradiag and assist Labonne’s marketing team in making the transition into their new responsibilities.
